Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, Lanzavecchia A et al (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8:639–646. https://doi.org/10.1038/ni1467
Article CAS PubMed Google Scholar
Mills KHG (2023) IL-17 and IL-17-producing cells in protection versus pathology. Nat Rev Immunol 23:38–54. https://doi.org/10.1038/s41577-022-00746-9
Article CAS PubMed Google Scholar
O’Quinn DB, Palmer MT, Lee YK, Weaver CT (2008) Emergence of the Th17 pathway and its role in host defense. Adv Immunol 99:115–163. https://doi.org/10.1016/S0065-2776(08)00605-6
Article CAS PubMed Google Scholar
Zenobia C (2000) Hajishengallis G (2015) Basic biology and role of interleukin-17 in immunity and inflammation. Periodontol 69:142–159. https://doi.org/10.1111/prd.12083
Onishi RM, Gaffen SL (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129:311–321. https://doi.org/10.1111/j.1365-2567.2009.03240.x
Article CAS PubMed PubMed Central Google Scholar
Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS et al (2015) IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature 522:345–348. https://doi.org/10.1038/nature14282
Article CAS PubMed PubMed Central Google Scholar
Huangfu L, Li R, Huang Y, Wang S (2023) The IL-17 family in diseases: from bench to bedside. Signal Transduct Target Ther 8:402. https://doi.org/10.1038/s41392-023-01620-3
Article CAS PubMed PubMed Central Google Scholar
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P et al (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med 373:2534–2548. https://doi.org/10.1056/NEJMoa1505066
Article CAS PubMed Google Scholar
Fragoulis GE, Siebert S (2020) Treatment strategies in axial spondyloarthritis: what, when and how? Rheumatology (Oxford).59:iv79-iv89. https://doi.org/10.1093/rheumatology/keaa435
Krainer J, Siebenhandl S, Weinhausel A (2020) Systemic autoinflammatory diseases. J Autoimmun 109:102421. https://doi.org/10.1016/j.jaut.2020.102421
Article CAS PubMed PubMed Central Google Scholar
Galozzi P, Negm O, Bindoli S, Tighe P, Sfriso P, Punzi L (2022) A Pro-Inflammatory Signature Constitutively Activated in Monogenic Autoinflammatory Diseases. Int J Mol Sci.23. https://doi.org/10.3390/ijms23031828
Magnol M, Couvaras L, Degboe Y, Delabesse E, Bulai-Livideanu C, Ruyssen-Witrand A, et al. (2021) VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy. Rheumatology (Oxford).60:e314-e315. https://doi.org/10.1093/rheumatology/keab211
Ovadia A, Livneh A, Feld O, Ben-Zvi I, Kukuy E, Kivity S et al (2013) T helper 17 polarization in familial Mediterranean fever. Genes Immun 14:212–216. https://doi.org/10.1038/gene.2013.6
Article CAS PubMed Google Scholar
Schwartz DM, Kitakule MM, Dizon BL, Gutierrez-Huerta C, Blackstone SA, Burma AM et al (2021) Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features. Ann Rheum Dis 80:788–795. https://doi.org/10.1136/annrheumdis-2020-219137
Article CAS PubMed Google Scholar
Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9:556–567. https://doi.org/10.1038/nri2586
Article CAS PubMed PubMed Central Google Scholar
Isailovic N, Daigo K, Mantovani A, Selmi C (2015) Interleukin-17 and innate immunity in infections and chronic inflammation. J Autoimmun 60:1–11. https://doi.org/10.1016/j.jaut.2015.04.006
Article CAS PubMed Google Scholar
Michel ML, Keller AC, Paget C, Fujio M, Trottein F, Savage PB et al (2007) Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204:995–1001. https://doi.org/10.1084/jem.20061551
Article CAS PubMed PubMed Central Google Scholar
Cua DJ, Tato CM (2010) Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 10:479–489. https://doi.org/10.1038/nri2800
Article CAS PubMed Google Scholar
Milpied P, Massot B, Renand A, Diem S, Herbelin A, Leite-de-Moraes M et al (2011) IL-17-producing invariant NKT cells in lymphoid organs are recent thymic emigrants identified by neuropilin-1 expression. Blood 118:2993–3002. https://doi.org/10.1182/blood-2011-01-329268
Article CAS PubMed Google Scholar
Ciccia F, Guggino G, Rizzo A, Saieva L, Peralta S, Giardina A et al (2015) Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. Ann Rheum Dis 74:1739–1747. https://doi.org/10.1136/annrheumdis-2014-206323
Article CAS PubMed Google Scholar
Carmona-Rivera C, Khaznadar SS, Shwin KW, Irizarry-Caro JA, O’Neil LJ, Liu Y et al (2019) Deficiency of adenosine deaminase 2 triggers adenosine-mediated NETosis and TNF production in patients with DADA2. Blood 134:395–406. https://doi.org/10.1182/blood.2018892752
Article CAS PubMed PubMed Central Google Scholar
Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W et al (2020) Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med 383:2628–2638. https://doi.org/10.1056/NEJMoa2026834
Article CAS PubMed PubMed Central Google Scholar
Mistry P, Carmona-Rivera C, Ombrello AK, Hoffmann P, Seto NL, Jones A et al (2018) Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome. Ann Rheum Dis 77:1825–1833. https://doi.org/10.1136/annrheumdis-2018-213746
Article CAS PubMed Google Scholar
Shahrara S, Pickens SR, Mandelin AM 2nd, Karpus WJ, Huang Q, Kolls JK et al (2010) IL-17-mediated monocyte migration occurs partially through CC chemokine ligand 2/monocyte chemoattractant protein-1 induction. J Immunol 184:4479–4487. https://doi.org/10.4049/jimmunol.0901942
Article CAS PubMed Google Scholar
Amatya N, Garg AV, Gaffen SL (2017) IL-17 Signaling: The Yin and the Yang. Trends Immunol 38:310–322. https://doi.org/10.1016/j.it.2017.01.006
Article CAS PubMed PubMed Central Google Scholar
Iwakura Y, Ishigame H, Saijo S, Nakae S (2011) Functional specialization of interleukin-17 family members. Immunity 34:149–162. https://doi.org/10.1016/j.immuni.2011.02.012
Article CAS PubMed Google Scholar
Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, et al. (1998) IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. Journal of Immunology (Baltimore, Md : 1950).160:3513–3521. https://pubmed.ncbi.nlm.nih.gov/9531313
Sieper J, Poddubnyy D, Miossec P (2019) The IL-23-IL-17 pathway as a therapeutic target in axial spondyloarthritis. Nat Rev Rheumatol 15:747–757. https://doi.org/10.1038/s41584-019-0294-7
Article CAS PubMed Google Scholar
Gravallese EM, Schett G (2018) Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis. Nat Rev Rheumatol 14:631–640. https://doi.org/10.1038/s41584-018-0091-8
Article CAS PubMed Google Scholar
Deng J, Yu XQ, Wang PH (2019) Inflammasome activation and Th17 responses. Mol Immunol 107:142–164. https://doi.org/10.1016/j.molimm.2018.12.024
Comments (0)